Cel-Sci
CVM
$1.44
Share price
-0.69%
Change (1 day)
-32.39%
Change (1 year)
Categories
Revenue for Cel-Sci (CVM)
Revenue in 2023 (TTM): N/A
In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cel-Sci from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | N/A | |
| 2022 | N/A | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | -100% |
| 2012 | $0.1 M | -63.17% |
| 2011 | $0.29 M | -57.72% |
| 2010 | $0.69 M | 1056.2% |
| 2009 | $0.06 M | |
| 2007 | $0.03 M | -65.49% |
| 2006 | $0.1 M | -49.82% |
| 2005 | $0.21 M | -33.43% |
| 2004 | $0.32 M | -3.2% |
| 2003 | $0.33 M | 55.2% |
| 2002 | $0.21 M | -21.33% |
| 2001 | $0.27 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | N/A | 🇺🇸 USA |
 Amgen AMGN | $28.19 B | N/A | 🇺🇸 USA |
 Xencor XNCR | $0.16 B | N/A | 🇺🇸 USA |
 Curis CRIS | $10.02 M | N/A | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $15.84 B | N/A | 🇮🇱 Israel |
 BioCryst Pharmaceuticals
BCRX | $0.33 B | N/A | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $1.02 B | N/A | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $0.06 M | N/A | 🇺🇸 USA |